Truist Financial’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$312K Sell
12,383
-94
-0.8% -$2.37K ﹤0.01% 2517
2026
Q1
$315K Buy
12,477
+170
+1% +$4.34K ﹤0.01% 2358
2025
Q4
$314K Buy
12,307
+45
+0.4% +$1.15K ﹤0.01% 2297
2025
Q3
$314K Buy
12,262
+3,059
+33% +$77.6K ﹤0.01% 2283
2025
Q2
$233K Buy
+9,203
New +$228K ﹤0.01% 2338
2024
Q3
Sell
-21,958
Closed -$539K 2606
2024
Q2
$539K Buy
21,958
+825
+4% +$20.1K ﹤0.01% 1930
2024
Q1
$524K Hold
21,133
﹤0.01% 1941
2023
Q4
$514K Buy
+21,133
New +$504K ﹤0.01% 1951

Other funds holding IBDX

Truist Financial's IBDX Position: Q2 2026 in Review

Truist Financial reduced its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 0.75% in Q2 2026, selling an estimated $2.37K and leaving 12,383 shares worth $312K. The position accounts for ﹤0.01% of the portfolio, ranked #2517.

Truist Financial first reported a position in IBDX in Q4 2023 and has held it in 8 quarters since. The position peaked at $539K in Q2 2024. 150 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

  • Truist Financial held 12,383 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $312K as of Q2 2026.
  • Truist Financial sold 94 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $2.37K.
  • iShares iBonds Dec 2032 Term Corporate ETF made up ﹤0.01% of Truist Financial's portfolio in Q2 2026, its #2517 holding.
  • Truist Financial first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q4 2023 and has held it in 8 quarters since.
  • Truist Financial's iShares iBonds Dec 2032 Term Corporate ETF position peaked at $539K in Q2 2024.
  • 150 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.